Dr. Kenneth Fields, MD

NPI: 1285659383
Total Payments
$10,634
2024 Payments
$2,685
Companies
45
Transactions
609
Medicare Patients
7,755
Medicare Billing
$962,736

Payment Breakdown by Category

Food & Beverage$10,597 (99.7%)
Education$37.02 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,597 604 99.7%
Education $37.02 5 0.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,198 145 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,372 91 $0 (2024)
Gilead Sciences, Inc. $1,321 62 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $457.72 28 $0 (2024)
Allergan Inc. $429.92 58 $0 (2019)
GENZYME CORPORATION $407.58 13 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $344.15 22 $0 (2024)
Medtronic, Inc. $287.19 2 $0 (2024)
Intercept Pharmaceuticals, Inc. $257.31 10 $0 (2024)
Olympus America Inc. $255.40 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,685 126 ABBVIE INC. ($527.63)
2023 $1,929 109 ABBVIE INC. ($371.71)
2022 $1,609 79 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($325.54)
2021 $605.37 10 BOSTON SCIENTIFIC CORPORATION ($191.86)
2020 $474.81 29 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($126.04)
2019 $1,415 96 AbbVie, Inc. ($381.94)
2018 $1,157 104 Allergan Inc. ($239.82)
2017 $759.04 56 AbbVie, Inc. ($283.12)

All Payment Transactions

609 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.37 General
Category: Immunology
12/18/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $20.34 General
Category: LIVER DISEASE
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $18.16 General
Category: Gastroenterology
12/17/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $20.99 General
Category: GI
12/12/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $13.49 General
Category: Immunology
12/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $12.50 General
Category: IMMUNOLOGY
12/10/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.25 General
Category: Gastroenterology
12/07/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $18.03 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/21/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $12.16 General
Category: ENDOCRINOLOGY
11/19/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $18.13 General
Category: GASTROENTEROLOGY
11/15/2024 Amgen Inc. Food and Beverage In-kind items and services $17.83 General
11/14/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $20.28 General
Category: LIVER DISEASE
11/13/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $16.71 General
Category: GI
11/12/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $12.33 General
Category: VIROLOGY
11/07/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.56 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/06/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $24.94 General
Category: INTERNAL MEDICINE
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $15.77 General
Category: Gastroenterology
10/29/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $15.46 General
Category: Immunology
10/28/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.84 General
Category: Gastroenterology
10/25/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $18.06 General
Category: GASTROENTEROLOGY
10/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.92 General
10/23/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $24.21 General
Category: Immunology
10/18/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.48 General
Category: GASTROENTEROLOGY
10/18/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $12.83 General
Category: GASTROENTEROLOGY
10/16/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.52 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 1,926 2,758 $870,344 $215,938
2022 22 1,785 2,817 $873,185 $229,550
2021 22 1,885 2,995 $958,760 $245,770
2020 23 2,159 3,508 $1.0M $271,478
Total Patients
7,755
Total Services
12,078
Medicare Billing
$962,736
Procedure Codes
88

All Medicare Procedures & Services

88 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 296 694 $86,750 $40,073 46.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 235 286 $42,900 $24,748 57.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 122 124 $138,880 $23,630 17.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 221 576 $46,080 $21,583 46.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 201 207 $31,050 $19,722 63.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 188 188 $38,594 $19,419 50.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 218 227 $187,275 $13,573 7.2%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 60 60 $45,000 $9,929 22.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 51 52 $41,600 $6,592 15.8%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 57 64 $57,600 $6,479 11.2%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 38 38 $28,500 $6,413 22.5%
45384 Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery Facility 2023 37 37 $36,075 $5,030 13.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 43 44 $38,500 $4,800 12.5%
43246 Insertion of stomach tube using a flexible endoscope Facility 2023 30 30 $26,700 $4,345 16.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 36 36 $4,860 $2,598 53.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 35 35 $3,850 $2,137 55.5%
43255 Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 11 12 $10,200 $1,785 17.5%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 13 14 $2,100 $1,269 60.4%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 16 16 $1,760 $1,002 56.9%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 18 18 $2,070 $811.80 39.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 427 1,359 $169,875 $71,796 42.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 239 300 $45,000 $25,689 57.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 113 117 $131,040 $21,636 16.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 176 176 $28,160 $18,702 66.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 143 151 $22,650 $15,135 66.8%

About Dr. Kenneth Fields, MD

Dr. Kenneth Fields, MD is a Gastroenterology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285659383.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Fields, MD has received a total of $10,634 in payments from pharmaceutical and medical device companies, with $2,685 received in 2024. These payments were reported across 609 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,597).

As a Medicare-enrolled provider, Fields has provided services to 7,755 Medicare beneficiaries, totaling 12,078 services with total Medicare billing of $962,736. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Memphis, TN
  • Active Since 07/12/2006
  • Last Updated 08/27/2019
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1285659383

Products in Payments

  • XIFAXAN (Drug) $864.86
  • Humira (Biological) $547.05
  • DUPIXENT (Biological) $542.63
  • LINZESS (Drug) $377.89
  • RINVOQ (Biological) $353.79
  • SKYRIZI (Biological) $336.30
  • Linzess (Drug) $308.81
  • ENTYVIO (Biological) $274.01
  • VIBERZI (Drug) $270.06
  • TRULANCE (Drug) $269.94
  • INTERSTIM (Device) $267.35
  • OCALIVA (Drug) $257.31
  • ZEPOSIA (Drug) $237.11
  • CREON (Drug) $185.41
  • SUCRAID (Drug) $178.59
  • OMVOH (Drug) $176.56
  • TERLIVAZ (Drug) $172.99
  • DIFICID (Drug) $169.30
  • Creon (Drug) $167.24
  • Olympus EndoTherapy Accessories (Device) $160.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Memphis